We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Randomized, double-blind, placebo-controlled trial of sulindac in individuals at risk for melanoma: evaluation of potential chemopreventive activity.
- Authors
Curiel-Lewandrowski, Clara; Swetter, Susan M; Einspahr, Janine G; Hsu, Chiu-Hsieh; Nagle, Ray; Sagerman, Paul; Tangrea, Joseph; Parnes, Howard; Alberts, David S; Chow, Hsiao-Hui
- Abstract
Reduced melanoma risk has been reported with regular use of nonsteroidal anti-inflammatory drugs (NSAIDs). However, the ability of NSAIDs to reach melanocytes in vivo and modulate key biomarkers in preneoplastic lesions such as atypical nevi has not been evaluated.
- Publication
Cancer, 2012, Vol 118, Issue 23, p5848
- ISSN
1097-0142
- Publication type
Journal Article
- DOI
10.1002/cncr.27540